Records containing: Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-04-15An Open Label, Phase Ia/Ib Dose Finding Study With BI 894999 Orally Administered Once a Day in Patients With Advanced Malignancies, With Repeated Administration in Patients With Clinical Benefit
-
CLINICAL_TRIALS study record update · 2024-04-15A Phase II Clinical Trial Evaluating the Efficacy of Adding Intraluminal Brachytherapy After Concurrent Chemoradiotherapy (CCRT) for Local-regional Thoracic Esophageal Cancer.
-
CLINICAL_TRIALS study record update · 2024-04-12Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy (COMPAR-G) in Gastric Cancer Patient.
-
CLINICAL_TRIALS study record update · 2024-03-18Assessment of Safety and Recommended Phase 2 Dose of Autologous T Cells Engineered With an Affinity-enhanced TCR Targeting NY ESO 1 and LAGE 1a, and Co-expressing the dnTGF-βRII (GSK3845097) in Participants With NY ESO 1 and/or LAGE 1a Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
-
CLINICAL_TRIALS study record update · 2024-03-15A Phase 1a/b, Open-Label, Dose-Escalation and Expansion Study of IK-175, an Oral Aryl Hydrocarbon Receptor (AHR) Inhibitor, as a Single Agent and in Combination With Nivolumab, a PD-1 Checkpoint Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-03-13A Prospective, Randomized Trial Assessing the Feasibility of an Advance Care Planning Intervention for Patients Hospitalized in a French Cancer Center
-
CLINICAL_TRIALS study record update · 2024-03-12A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS-22M6E or ASG-22CE Given as Monotherapy Followed by Expansion Cohorts in Subjects With Malignant Solid Tumors That Express Nectin-4
-
CLINICAL_TRIALS study record update · 2024-03-07Genotoxicity Assessment for Patients Receiving Large Field Irradiation
-
CLINICAL_TRIALS study record update · 2024-03-06Pilot Study of Personalized Neoantigen Peptide Vaccines and Leukine for the Treatment of Neoplasms
-
CLINICAL_TRIALS study record update · 2024-03-06Pilot Study of Personalized Neoantigen Peptide Vaccines for the Treatment of Neoplasms
-
CLINICAL_TRIALS study record update · 2024-03-05Lymphaticovenous Anastomosis as a Surgical Treatment for Breast Cancer-Related Lymphedema
-
CLINICAL_TRIALS study record update · 2024-03-04Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
-
CLINICAL_TRIALS study record update · 2024-03-04An Open-label, Phase I Trial to Determine the Maximum-tolerated Dose and Investigate Safety, Pharmacokinetics and Efficacy of BI 905677 Administered Intravenously in Patients With Advanced Solid Tumours
-
CLINICAL_TRIALS study record update · 2024-02-29Community Engagement in the Development of Oncology Navigation Training
-
CLINICAL_TRIALS study record update · 2024-02-20Impact of Physical Therapy Intervention on Foot and Ankle Function in Children and Adolescents With Non-CNS Cancers
-
CLINICAL_TRIALS study record update · 2024-02-12A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-033, an Anti-LAG-3 Monoclonal Antibody, Alone and in Combination With an Anti-PD-1 in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-02-07Evaluation of the Effect of the Combination of the Natural Products Glizigen® and Ocoxin®-Viusid® in the Treatment of High-grade Cervical Intraepithelial Lesions. Phase II
-
CLINICAL_TRIALS study record update · 2024-02-07Autologous Dendritic Cell-cytokine Induced Killer Cell Immunotherapy Combined Anti-PD1 in Advanced NSCLC: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-02-07A Prospective Study of Anti-PD-1 Alone or Combined Wih Autologous DC-CIK Cell Therapy in Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-02-05A Screening Protocol to Support Preliminary Eligibility for Clinical Trials Evaluating Safety and Efficacy of Adoptive Cell Therapies in Participants With Solid Tumors and Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2024-02-01Families Addressing Cancer Together (FACT): A Pilot Randomized Trial
-
CLINICAL_TRIALS study record update · 2024-01-30AnovaOS Network Powered Patient Registry
-
CLINICAL_TRIALS study record update · 2024-01-30A Phase I/II Study of Oral TY-1091 in Adult Patients With Advanced Solid Tumors, Including RET-Fusion Non-Small Cell Lung Cancer, RET-Mutation Medullary Thyroid Cancer, and Other Tumors With RET Alterations
-
CLINICAL_TRIALS study record update · 2024-01-26Preparing Family Caregivers of Very Ill Patients for End-of-Life Decision Making
-
CLINICAL_TRIALS study record update · 2024-01-23A Phase 2, Open-Label Study to Evaluate the Safety and Antitumor Activity of Praluzatamab Ravtansine (CX-2009) in Advanced HR-Positive/HER2-Negative Breast Cancer and of Praluzatamab Ravtansine as Monotherapy and in Combination With Pacmilimab (CX-072) in Advanced Triple-Negative Breast Cancer (CTMX-2009-002)